1. No category

Current Research Studies Open for
Patient Enrollment at Sacred Heart Cancer Center
For more information about these clinical trials or to see if you may qualify for enrollment, please
contact one of our Clinical Research Coordinators: Betsy Brou, RN (850-416-4611), Toni Hyatt, RN (850416-2730) or Walid Kara (850-416-6316).
Cancer Type
Trial #
Trial Information/Description
Brain
A221101
The Use of Armodafinil (Nuvigil) To Reduce Cancer-Related Fatigue in Patients with
Glioma: A Randomized, Novel Adaptive Design Study.
Breast
CLEE011E2301
SWOG 1007
SWOG S1207
S1202
M12-914
S1222
A randomized, double-blind, placebo-controlled study of LEE011 or placebo +
tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and
goserelin for premenopausal women with hormone receptor positive, HER2negative, advanced breast cancer
A Phase III Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and
HER2-Negative Breast Cancer with Recurrence Score of 25 or Less.
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant
Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone
Receptor-Positive and HER2/NEU Negative Breast Cancer
A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of
Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with
Early Stage Breast Cancer
Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCAAssociated Breast Cancer
Fulvestrant vs. Fulvestrant + Evorilimus vs. Fulvestrant + Evorolimus +Anastrazole for
HR(+), HER2 (-), Postmenopausal, Advanced Breast with no prior therapy for
advanced disease.
Chronic Lymphocytic Leukemia (CLL)
A041202
UTX-IB-301
Bendamustine + Rituximab Vs. Ibrutinib + Rituximab Vs. Ibrutinib Alone in
Untreated CLL pt≥65
A Randomized Study to Assess the Efficacy and Safety of Ublituximab + Ibrutinib vs.
Ibrutinib Alone, in Previously Treated High-Risk CLL
Genitourinary (GU)
SO931
EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III
Study.
A031201
Phase III Trial of Enzalutamide Versus Enzalutamide, Abiraterone And Prednisone For
Castration Resistant Metastatic Prostate Cancer.
Sacred Heart Cancer Center Clinical Research Office • 1545 Airport Boulevard, 3rd Floor • Pensacola, FL 32504
Updated: 6/30/2015
Current Research Studies Open for
Patient Enrollment at Sacred Heart Cancer Center
Gynecologic
USA
NRG-CC002
2012-0543
A Novel Method of Screening for Ovarian Cancer using Gynecologic Fluids and
Mucus in post-menopausal women over the age of 50
Pre-Operative Assessment and Post-Operative Outcomes of Elderly Women with
Gynecologic Cancers
A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in
Patients with Advanced or Recurrent Endometrial Carcinoma
Lung
S1400
S1403
Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous
Cell Lung Cancer
A Randomized Trial of Afatinib + Cetuximab VS Afatinib Alone in Treatment-Naïve
Patients with Advanced, EGFR Mutated NSCLC
Lymphoma
NHL-008
Randomized study of lenalidomide plus rituximab maintenance therapy followed by
lenalidomide single-agent maintenance versus rituximab maintenance in subjects with
relapsed/refractory follicular, marginal zone or mantle cell lymphoma.
Multiple Myeloma
E1A11
Randomized Trial of Bortezomib + Lenalidomide + Dexamethasone (VRd) vs.
Carfilzomib + Lenalidomide + Dexamethasone (CRd) Followed by Limited or Indefinite
Lenalidomide Maintenance in Patients With Newly Diagnosed, Symptomatic Multiple
Myeloma.
Supportive
CONNECT MM
CONNECT MDS/AML
REVEAL
The Multiple Myeloma Disease Registry - symptomatic and starting initial treatment
for MM.
The Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Disease Registry
Prospective Observational Study of Patients with Polycythemia Vera in US Clinical
Practices (REVEAL)
Sacred Heart Cancer Center Clinical Research Office • 1545 Airport Boulevard, 3rd Floor • Pensacola, FL 32504
Updated: 6/30/2015